Latest news
Loading news…
Fibrotech Therapeutics
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Wonga Park, Victoria, Australia Founded 2006 11-50 employees For Profit
Fibrotech Therapeutics is developing novel drug candidates for the treatment of the fibrosis in kidney disease.
Fibrotech Therapeutics was acquired by Shire in 2014 for $75M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Patents
7
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 0
- Patents granted
- 7
- Trademarks
- 0
- Top patent class
- a61
- IT spend
- $9M
Company Info
- Founded
- 2006
- Employees
- 11-50
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- News articles
- 4
- HQ
- Wonga Park, Victoria, Australia
- Region
- Asia-Pacific (APAC), Australasia
- Exit date
- May 2, 2014
- Closed
- Dec 11, 2019
Signals & Scores
- Heat score
- Low
- Trend (7d)
- -0.4
- Trend (30d)
- 2.9
- Trend (90d)
- 2.1
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Fibrotech Therapeutics
Loading news…
FAQs about Fibrotech Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.